Markel Corp
NYSE:MKL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (10.2), the stock would be worth $1 726.62 (2% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 10.4 | $1 759.21 |
0%
|
| 3-Year Average | 10.2 | $1 726.62 |
-2%
|
| 5-Year Average | 9.9 | $1 682.87 |
-4%
|
| Industry Average | 13.1 | $2 219.96 |
+26%
|
| Country Average | 22.9 | $3 877.64 |
+120%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
$25.7B
|
/ |
Jan 2026
$2.1B
|
= |
|
|
$25.7B
|
/ |
Dec 2026
$1.5B
|
= |
|
|
$25.7B
|
/ |
Dec 2027
$1.6B
|
= |
|
|
$25.7B
|
/ |
Dec 2028
$1.8B
|
= |
|
|
$25.7B
|
/ |
Dec 2029
$2.1B
|
= |
|
|
$25.7B
|
/ |
Dec 2030
$2.1B
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Markel Corp
NYSE:MKL
|
22.1B USD | 10.4 | |
| CH |
|
Chubb Ltd
NYSE:CB
|
126.6B USD | 11.2 | |
| US |
|
Progressive Corp
NYSE:PGR
|
117.3B USD | 10.1 | |
| JP |
|
Tokio Marine Holdings Inc
TSE:8766
|
13.8T JPY | 13 | |
| US |
|
Travelers Companies Inc
NYSE:TRV
|
64.3B USD | 8.5 | |
| US |
|
Allstate Corp
NYSE:ALL
|
55.2B USD | 5.4 | |
| CN |
|
People's Insurance Company Group of China Ltd
SSE:601319
|
314B CNY | 6.7 | |
| ZA |
S
|
Santam Ltd
JSE:SNT
|
44.1B ZAR | 10.9 | |
| CN |
|
PICC Property and Casualty Co Ltd
HKEX:2328
|
312.5B HKD | 7.2 | |
| JP |
|
MS&AD Insurance Group Holdings Inc
TSE:8725
|
5.9T JPY | 8.2 | |
| CA |
|
Fairfax Financial Holdings Ltd
TSX:FFH
|
50.7B CAD | 7.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.3 |
| Median | 22.9 |
| 70th Percentile | 33.2 |
| Max | 1 826 183.3 |
Other Multiples
Markel Corp
Glance View
Markel Corporation is often likened to a miniature Berkshire Hathaway, reflecting its dual prowess in the insurance and investment realms. Founded in 1930, the company began as a niche insurance player, focusing on specialty lines where standard insurance companies hesitated to tread. This set the foundation for its unique underwriting philosophy: subscribing to risks that require a unique understanding not replicated across the industry. The insurance segment, comprising the majority of Markel's revenue stream, has thus transformed into a bastion of reliability, driven by disciplined underwriting that enables it to write profitable policies. This niche expertise allows Markel to command higher margins and maintain a competitive edge in the complex landscape of insurance underwriting. Much like its famed counterpart in Omaha, Markel goes beyond insurance, leveraging the float generated from its insurance operations to invest in public equities and acquire entire businesses. This dual engine of profit generation—insurance underwriting and investment income—forms the crux of Markel's business model. The company is adept at identifying and nurturing high-growth opportunities, successfully capturing value from sectors including healthcare, transportation, and manufacturing, primarily through its Markel Ventures segment. This diversification allows Markel Corporation to reinvest its hefty insurance float strategically, akin to planting seeds for future growth. Thus, with a keen eye on both underwriting accuracy and strategic investments, Markel deftly navigates the art of harmonizing insurance operations with investment genius.